Current Eye Research
ISSN: 0271-3683 (Print) 1460-2202 (Online) Journal homepage: http://www.tandfonline.com/loi/icey20
Correction to: VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans To cite this article: (2015) Correction to: VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans, Current Eye Research, 40:8, 862-862 To link to this article: http://dx.doi.org/10.3109/02713683.2014.936254
Published online: 30 Jun 2014.
Submit your article to this journal
Article views: 116
View related articles
View Crossmark data
Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=icey20 Download by: [Australian National University]
Date: 05 November 2015, At: 14:10
Current Eye Research, 2015; 40(8): 862 ! Informa Healthcare USA, Inc. ISSN: 0271-3683 print / 1460-2202 online DOI: 10.3109/02713683.2014.936254
ERRATUM
Barak V, Pe’er J, Kalickman I, Frenkel S. VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans. Current Eye Res 2011;36:386–390. Following publication of this article, an error has been identified in Figure 2. The image accompanying the Figure 2 legend is incorrect. The proper Figure 2, and its legend, appears below.
4.5 4 3.5 Relative VEGF level
Downloaded by [Australian National University] at 14:10 05 November 2015
Correction to: VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans
3 2.5 2 1.5
1.35
1 0.5 0 Pre/Pre
Post/Pre
FIGURE 2 Pre- and post-metastatic serum VEGF levels are plotted for each patient. Serum VEGF levels were normalized by dividing them by the Pre-metastatic level for each patient. The black line indicates the mean level (paired t-test, p = 0.0595). Excluding the highest two as outliers lowers the mean to 1.09 and the paired t-test to p = 0.2131.
862
ISSN: 0271-3683 (Print) 1460-2202 (Online) Journal homepage: http://www.tandfonline.com/loi/icey20
Correction to: VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans To cite this article: (2015) Correction to: VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans, Current Eye Research, 40:8, 862-862 To link to this article: http://dx.doi.org/10.3109/02713683.2014.936254
Published online: 30 Jun 2014.
Submit your article to this journal
Article views: 116
View related articles
View Crossmark data
Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=icey20 Download by: [Australian National University]
Date: 05 November 2015, At: 14:10
Current Eye Research, 2015; 40(8): 862 ! Informa Healthcare USA, Inc. ISSN: 0271-3683 print / 1460-2202 online DOI: 10.3109/02713683.2014.936254
ERRATUM
Barak V, Pe’er J, Kalickman I, Frenkel S. VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans. Current Eye Res 2011;36:386–390. Following publication of this article, an error has been identified in Figure 2. The image accompanying the Figure 2 legend is incorrect. The proper Figure 2, and its legend, appears below.
4.5 4 3.5 Relative VEGF level
Downloaded by [Australian National University] at 14:10 05 November 2015
Correction to: VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans
3 2.5 2 1.5
1.35
1 0.5 0 Pre/Pre
Post/Pre
FIGURE 2 Pre- and post-metastatic serum VEGF levels are plotted for each patient. Serum VEGF levels were normalized by dividing them by the Pre-metastatic level for each patient. The black line indicates the mean level (paired t-test, p = 0.0595). Excluding the highest two as outliers lowers the mean to 1.09 and the paired t-test to p = 0.2131.
862
